Deficiency of MARCO was found to significantly inhibit tumor progression and metastasis in a mouse model of pancreatic cancer, and correlation of clinical data showed a strong trend toward poorer survival in patients with high CD163 and MARCO macrophage infiltration ( 32 ).
← all excerpts
Targeting the CSF1/CSF1R signaling pathway: an innovative strategy for ultrasound combined with macrophage exhaustion in pancreatic cancer therapy.
1
—
—